 LA JOLLA, Calif., Jan. 11, 2021 GLOBE NEWSWIRE -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market NASDAQ:MNOV and the JASDAQ Market of the Tokyo Stock Exchange Code Number: 4875, today announced that it has entered into a Securities Purchase Agreement pursuant to which MediciNova has agreed to issue US20 million in shares of its common stock to 3D Opportunity Master Fund, a fund managed by 3D Investment Partners Pte. Ltd. 3D, in a private placement transaction. 